A major goal of cancer genomics is to identify somatic mutations that play a role in tumor initiation or progression. Somatic mutations within transcription factors are of particular interest, as gene expression dysregulation is widespread in cancers. The substantial gene expression variation evident across tumors suggests that numerous regulatory factors are likely to be involved and that somatic mutations within them may not occur at high frequencies across patient cohorts, thereby complicating efforts to uncover which ones are cancer-relevant. Here we analyze somatic mutations within the largest family of human transcription factors, namely those that bind DNA via Cys2His2 zinc finger domains. Specifically, to hone in on important mutati...
Efforts to identify driver mutations in cancer have largely focused on genes, whereas non-coding seq...
All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer cl...
Abstract The genetic mutations that contribute to the transformation of healthy cells into cancerous...
<div><p>A major goal of cancer genomics is to identify somatic mutations that play a role in tumor i...
<p>Each mutated gene is represented as a column in which a blue, red, or green bar indicates whether...
Identifying driver mutations and their functional consequences is critical to our understanding of c...
Aberrant regulation of gene expression in cancer can promote survival and proliferation of cancer ce...
The KRAB‐ZNF (Krüppel‐associated box domain zinc finger) gene family is composed of a large number o...
Abstract Background The mutational processes underlying non-coding cancer mutations and their biolog...
CCCTC-binding factor (CTCF) plays fundamental roles in transcriptional regulation and chromatin arch...
Efforts to identify driver mutations in cancer have largely focused on genes, whereas non-coding seq...
Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Her...
Most cancer DNA sequencing studies have prioritized recurrent non-synonymous coding mutations in ord...
Background: Recent advances in sequencing technologies enable the large-scale identification of gene...
Identifying driver mutations and their functional consequences is critical to our understand-ing of ...
Efforts to identify driver mutations in cancer have largely focused on genes, whereas non-coding seq...
All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer cl...
Abstract The genetic mutations that contribute to the transformation of healthy cells into cancerous...
<div><p>A major goal of cancer genomics is to identify somatic mutations that play a role in tumor i...
<p>Each mutated gene is represented as a column in which a blue, red, or green bar indicates whether...
Identifying driver mutations and their functional consequences is critical to our understanding of c...
Aberrant regulation of gene expression in cancer can promote survival and proliferation of cancer ce...
The KRAB‐ZNF (Krüppel‐associated box domain zinc finger) gene family is composed of a large number o...
Abstract Background The mutational processes underlying non-coding cancer mutations and their biolog...
CCCTC-binding factor (CTCF) plays fundamental roles in transcriptional regulation and chromatin arch...
Efforts to identify driver mutations in cancer have largely focused on genes, whereas non-coding seq...
Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Her...
Most cancer DNA sequencing studies have prioritized recurrent non-synonymous coding mutations in ord...
Background: Recent advances in sequencing technologies enable the large-scale identification of gene...
Identifying driver mutations and their functional consequences is critical to our understand-ing of ...
Efforts to identify driver mutations in cancer have largely focused on genes, whereas non-coding seq...
All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer cl...
Abstract The genetic mutations that contribute to the transformation of healthy cells into cancerous...